MBBS OSCE · General Medicine
OSCE — Peripheral Neuropathy
Eight-minute OSCE station on Peripheral Neuropathy: focused history, examination priorities, investigations, emergency and definitive management.
On this page
Study tools
Exam tags
Brief (to candidate)
You will assess a patient with a presentation consistent with Peripheral Neuropathy.
You have 8 minutes to take a focused history, outline examination, investigations, and management including red flags.
Clinical context
Peripheral neuropathy is any disorder of the peripheral nerves; clinically the term usually denotes polyneuropathy — a diffuse, usually symmetric process. The commonest pattern worldwide is a distal symmetric (length-dependent), sensorimotor, axonal polyneuropathy producing numbness, tingling and burning pain in a glove-and-stocking distribution, with loss of ankle reflexes. The commonest cause is diabetes mellitus (diabetic peripheral neuropathy, DPN); other leading causes are alcohol, vitamin B12 deficiency, drugs (chemotherapy, vincristine, isoniazid, metronidazole, amiodarone, phenytoin), uraemia, hereditary (Charcot-Marie-Tooth), vasculitic and CIDP. Diagnosis combines the clinical patt
Candidate tasks
- Clarify onset, severity, associated features, and red-flag symptoms.
- State focused examination priorities.
- List first-line investigations and any named score/criteria.
- Give immediate resuscitation steps.
- Outline definitive management with doses/routes where standard.
- Name complications and disposition (ward / HDU / theatre / discharge safety-net).
- Mention one special-population modifier (pregnancy, child, elderly, CKD).
Examiner checklist
| Domain | Pass behaviours |
|---|---|
| Definition | Correct working diagnosis language |
| Assessment | Focused, prioritised, red flags sought |
| Investigations | Appropriate first-line + interpretation |
| Emergency care | ABC / time-critical actions first |
| Definitive care | Specific drugs/procedures, not generic phrases |
| Safety | Acute or rapidly progressive weakness with neuropathy — GBS or vasculitic; urgen |
| Safety | Asymmetric, painful, stepwise neuropathy — mononeuritis multiplex (vasculitis); |
| Safety | Progressive numbness in a glove-and-stocking distribution — screen for diabetes; |
| Communication | Clear plan and safety-netting |
Model outline
Lead with the working diagnosis and life threats. Resuscitate before definitive tests when unstable. Use guideline-standard therapy with named agents and doses. Document escalation criteria and follow-up. A safe candidate is specific, structured, and never delays critical care for non-urgent imaging.